| Full text | |
| Author(s): |
Silveira de Almeida, Luisa Maria
;
Aleixo de Carvalho, Lara Soares
;
Gazolla, Matheus Coutinho
;
Silva Pinto, Pedro Luiz
;
Nascimento da Silva, Marcos Paulo
;
de Moraes, Josue
;
Da Silva Filho, Ademar A.
Total Authors: 7
|
| Document type: | Journal article |
| Source: | Evidence-based Complementary and Alternative Medicine; v. 2016, p. 9-pg., 2016-01-01. |
| Abstract | |
Human schistosomiasis, caused by trematode worms of the genus Schistosoma, is one of the most significant neglected tropical diseases, affecting more than 200 million individuals worldwide and praziquantel is the only available drug to treat this disease. Artemisia absinthium L. and Tanacetum parthenium L. are species popularly used as anthelmintics. We investigated the in vitro schistosomicidal activity of crude extracts of A. absinthium ( AA) and T. parthenium ( TP) and their isolated compounds. AA and TP, at 200 mu g/mL, were active, causing 100% mortality of all adult worms. Chromatographic fractionation of AA leads to isolation of artemetin and hydroxypelenolide, while santin, apigenin, and parthenolide were isolated from TP. Artemetin, hydroxypelenolide, santin, and apigenin, at 100 mu M, were inactive against adultworms. Parthenolide ( 12.5 to 100 mu M) caused 100% mortality, tegumental alterations, and reduction of motor activity of all adult worms of S. mansoni, without affecting mammalian cells. Confocal laser scanning microscopy showed tegumental morphological alterations and changes on the numbers of tubercles of S. mansoni worms. This report provides the first evidence for the in vitro activity of parthenolide against adult worms of S. mansoni, opening the route to further schistosomicidal studies with this compound. (AU) | |